RU2018147553A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018147553A3 RU2018147553A3 RU2018147553A RU2018147553A RU2018147553A3 RU 2018147553 A3 RU2018147553 A3 RU 2018147553A3 RU 2018147553 A RU2018147553 A RU 2018147553A RU 2018147553 A RU2018147553 A RU 2018147553A RU 2018147553 A3 RU2018147553 A3 RU 2018147553A3
- Authority
- RU
- Russia
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2018147553A RU2741095C2 (en) | 2018-12-29 | 2018-12-29 | Method of producing cell lines stably producing human monoclonal antibodies of class igg |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2018147553A RU2741095C2 (en) | 2018-12-29 | 2018-12-29 | Method of producing cell lines stably producing human monoclonal antibodies of class igg |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2018147553A3 true RU2018147553A3 (en) | 2020-06-29 |
RU2018147553A RU2018147553A (en) | 2020-06-29 |
RU2741095C2 RU2741095C2 (en) | 2021-01-22 |
Family
ID=71509320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018147553A RU2741095C2 (en) | 2018-12-29 | 2018-12-29 | Method of producing cell lines stably producing human monoclonal antibodies of class igg |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2741095C2 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
US4764465A (en) * | 1984-04-26 | 1988-08-16 | Cetus Corporation | Human monoclonal antibody against group A red blood cells |
WO2010017381A2 (en) * | 2008-08-07 | 2010-02-11 | The Regents Of The University Of Colorado, A Body Corporate | Methods for the diagnosis of varicella zoster virus infection |
CA2778953C (en) * | 2009-11-13 | 2020-01-14 | Dana-Farber Cancer Institute, Inc. | Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 |
CN111499755A (en) * | 2012-08-03 | 2020-08-07 | 丹娜法伯癌症研究院 | anti-PD-L1 and PD-L2 double-binding antibody single reagents and methods of use thereof |
-
2018
- 2018-12-29 RU RU2018147553A patent/RU2741095C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2018147553A (en) | 2020-06-29 |
RU2741095C2 (en) | 2021-01-22 |